Action Point Financial Planning’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Other funds holding BMRN
Action Point Financial Planning's BMRN Position: Q3 2026 in Review
Action Point Financial Planning sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2026, closing a stake of 149 shares — an estimated $8.24K sold.
Action Point Financial Planning first reported a position in BMRN in Q2 2026 and held it in 1 quarter. The position peaked at $8.24K in Q2 2026. 567 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.
- Action Point Financial Planning reported no remaining BioMarin Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Action Point Financial Planning sold 149 BioMarin Pharmaceuticals shares in Q3 2026, an estimated $8.24K.
- Action Point Financial Planning first reported a position in BioMarin Pharmaceuticals in Q2 2026 and held it in 1 quarter.
- Action Point Financial Planning's BioMarin Pharmaceuticals position peaked at $8.24K in Q2 2026.
- 567 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.
Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.